William Blair Investment Management LLC Purchases 152,299 Shares of Establishment Labs Holdings Inc. $ESTA

William Blair Investment Management LLC increased its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 17.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,017,543 shares of the company’s stock after acquiring an additional 152,299 shares during the period. William Blair Investment Management LLC owned about 3.50% of Establishment Labs worth $41,709,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ESTA. GSA Capital Partners LLP grew its holdings in shares of Establishment Labs by 25.0% during the third quarter. GSA Capital Partners LLP now owns 39,739 shares of the company’s stock worth $1,629,000 after purchasing an additional 7,954 shares during the last quarter. State of Wyoming acquired a new position in Establishment Labs during the 3rd quarter worth about $71,000. Principal Financial Group Inc. grew its holdings in Establishment Labs by 5.3% during the 3rd quarter. Principal Financial Group Inc. now owns 102,687 shares of the company’s stock worth $4,209,000 after acquiring an additional 5,134 shares during the last quarter. Tejara Capital Ltd increased its position in Establishment Labs by 31.2% in the 3rd quarter. Tejara Capital Ltd now owns 102,494 shares of the company’s stock valued at $4,201,000 after acquiring an additional 24,386 shares in the last quarter. Finally, Woodson Capital Management LP raised its stake in shares of Establishment Labs by 113.3% in the third quarter. Woodson Capital Management LP now owns 480,000 shares of the company’s stock worth $19,675,000 after acquiring an additional 255,000 shares during the last quarter. 72.91% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently commented on ESTA shares. Citigroup increased their price target on shares of Establishment Labs from $62.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Canaccord Genuity Group increased their price objective on Establishment Labs from $85.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday. Stephens boosted their target price on Establishment Labs from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 25th. JPMorgan Chase & Co. upped their price target on Establishment Labs from $71.00 to $80.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Finally, Mizuho raised their price target on Establishment Labs from $90.00 to $100.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Six equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $87.00.

Establishment Labs Stock Performance

Shares of Establishment Labs stock opened at $78.70 on Monday. The stock’s 50-day moving average is $71.30 and its 200-day moving average is $58.63. Establishment Labs Holdings Inc. has a one year low of $26.56 and a one year high of $83.31. The firm has a market cap of $2.29 billion, a price-to-earnings ratio of -45.23 and a beta of 0.91. The company has a debt-to-equity ratio of 15.06, a current ratio of 3.33 and a quick ratio of 2.10.

Establishment Labs (NASDAQ:ESTA) last released its earnings results on Tuesday, February 24th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.13. Establishment Labs had a negative return on equity of 197.22% and a negative net margin of 24.19%.The firm had revenue of $64.62 million for the quarter, compared to analysts’ expectations of $63.80 million. During the same quarter in the previous year, the business posted ($1.19) EPS. The business’s quarterly revenue was up 45.2% compared to the same quarter last year. Equities analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.